Abstract:Objective Medical imaging offered a non-invasive window to visualize tumors, with radiomics transforming these images into quantitative data for tumor phenotyping. However, the intricate web linking imaging features, clinical endpoints, and tumor biology was mostly uncharted. This study aimed to unravel the connections between CT imaging features and clinical characteristics, including tumor histopathological grading, clinical stage, and endocrine symptoms, alongside immunohistochemical markers of tumor cell growth, such as the Ki-67 index and nuclear mitosis rate. Approach We conducted a retrospective analysis of data from 137 patients with pancreatic neuroendocrine tumors who had undergone contrast-enhanced CT scans across two institutions. Our study focused on three clinical factors: pathological grade, clinical stage, and endocrine symptom status, in addition to two immunohistochemical markers: the Ki-67 index and the rate of nuclear mitosis. We computed both predefined (2D and 3D) and learning-based features (via sparse autoencoder, or SAE) from the scans. To unearth the relationships between imaging features, clinical factors, and immunohistochemical markers, we employed the Spearman rank correlation along with the Benjamini-Hochberg method. Furthermore, we developed and validated radiomics signatures to foresee these clinical factors. Main results The 3D imaging features showed the strongest relationships with clinical factors and immunohistochemical markers. For the association with pathological grade, the mean absolute value of the correlation coefficient (CC) of 2D, SAE, and 3D features was 0.3318±0.1196, 0.2149±0.0361, and 0.4189±0.0882, respectively. While for the association with Ki-67 index and rate of nuclear mitosis, the 3D features also showed higher correlations, with CC as 0.4053±0.0786 and 0.4061±0.0806. In addition, the 3D feature-based signatures showed optimal performance in clinical factor prediction. Significance We found relationships between imaging features, clinical factors, and immunohistochemical markers. The 3D features showed higher relationships with clinical factors and immunohistochemical markers.

Radiomics in pancreatic neuroendocrine tumors: methodological issues and clinical significance

Recent developments in the diagnosis of pancreatic neuroendocrine neoplasms

Radiomics Analysis Based on Diffusion Kurtosis Imaging and T2 Weighted Imaging for Differentiation of Pancreatic Neuroendocrine Tumors From Solid Pseudopapillary Tumors

Radiomics machine learning algorithm facilitates detection of small pancreatic neuroendocrine tumors on CT

Pancreatic Neuroendocrine Tumor: Prediction of Tumor Grades by Radiomics Models Based on Ultrasound Images

Preoperative Prediction of Lymph Node Metastases in Nonfunctional Pancreatic Neuroendocrine Tumors Using a Combined CT Radiomics-Clinical Model

Introduction to radiomics and radiogenomics in neuro-oncology: implications and challenges

Exploring the biological basis of CT imaging features in pancreatic neuroendocrine tumors: a two-center study

Radiomics in Oncology, Part 1: Technical Principles and Gastrointestinal Application in CT and MRI

Is radiomics a useful addition to magnetic resonance imaging in the preoperative classification of PitNETs?

Radiomics in medical imaging: pitfalls and challenges in clinical management

Radiomics analysis from magnetic resonance imaging in predicting the grade of nonfunctioning pancreatic neuroendocrine tumors: a multicenter study

Pancreatic Ductal Adenocarcinoma: Update of CT-Based Radiomics Applications in the Pre-Surgical Prediction of the Risk of Post-Operative Fistula, Resectability Status and Prognosis

Pancreatic Cancer: Assessment of Neoadjuvant Chemotherapy Outcome Based on Radiomics of Pretreatment Computed Tomography.

Current and New Challenges in the Management of Pancreatic Neuroendocrine Tumors: The Role of miRNA-Based Approaches as New Reliable Biomarkers

[Imaging of pancreatic neuroendocrine tumors]

Radiomics and Magnetic Resonance Imaging of Rectal Cancer: From Engineering to Clinical Practice

Using Quantitative Imaging for Personalized Medicine in Pancreatic Cancer: A Review of Radiomics and Deep Learning Applications

Current state of radiomics in pediatric neuro-oncology practice: a systematic review

Radiomics: the facts and the challenges of image analysis

Basics and Frontiers on Pancreatic Cancer for Radiation Oncology: Target Delineation, SBRT, SIB technique, MRgRT, Particle Therapy, Immunotherapy and Clinical Guidelines